Clinical Trials List
Protocol NumberKN-4802
Completed
2022-05-01 - 2024-08-16
Phase I
Recruiting3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- JHE-CYUAN GUO 無
- Yu-Chieh Tsai 無
- Chih-Hung Hsu 無
- TSUNG-HAO LIU 無
- YU-YUN SHAO 無
- FU-JEN HSUEH 無
- Ying-Chun Shen 無
- Chiun Hsu 無
- 徐偉勛 無
- Jih-Hsiang Lee 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Pin Li 無
- Mu-Hsin Chang 無
- Jiun-I Lai 無
- 姜乃榕 無
- San-Chi Chen 無
- Chueh-Chuan Yen 無
- Yi-Ping Hung 無
- Yee Chao 無
- Chien-An Liu 無
- Tien-Hua Chen 無
- 林泰祺 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang 無
- Jeng-Shiun Du 無
- Wen-Jeng Wu 無
- 高育青 無
- Ching-Chia Li 無
- I-CHEN WU 無
- Tsung-Jang Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
120 participants
